These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32171950)

  • 1. A clinical score has utility in tuberculosis case-finding among patients with HIV: A feasibility study from Bissau.
    Aunsborg JW; Hønge BL; Jespersen S; Rudolf F; Medina C; Correira FG; Johansen IS; Wejse C;
    Int J Infect Dis; 2020 Mar; 92S():S78-S84. PubMed ID: 32171950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.
    Peter J; Theron G; Chanda D; Clowes P; Rachow A; Lesosky M; Hoelscher M; Mwaba P; Pym A; Dheda K;
    BMC Infect Dis; 2015 Jul; 15():262. PubMed ID: 26156025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can tuberculosis case finding among health-care seeking adults be improved? Observations from Bissau.
    Rudolf F; Haraldsdottir TL; Mendes MS; Wagner AJ; Gomes VF; Aaby P; Østergaard L; Eugen-Olsen J; Wejse C
    Int J Tuberc Lung Dis; 2014 Mar; 18(3):277-85. PubMed ID: 24670561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF.
    Orlando S; Triulzi I; Ciccacci F; Palla I; Palombi L; Marazzi MC; Giuliano M; Floridia M; Mancinelli S; Mutemba E; Turchetti G
    PLoS One; 2018; 13(7):e0200523. PubMed ID: 30024890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.
    Shah M; Hanrahan C; Wang ZY; Dendukuri N; Lawn SD; Denkinger CM; Steingart KR
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD011420. PubMed ID: 27163343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
    Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of Determine TB-LAM Ag to detect TB in HIV infected patients associated with diagnostic methods used in Brazilian public health units.
    Benjamin A; Cavalcante SC; Jamal LF; Arakaki-Sanchez D; de Lima JN; Pilotto JH; de Oliveira Junior FI; Souza TNL; Lourenço MC; de Mello MB; do Brasil PEAA; Barreira D; Rolla V
    PLoS One; 2019; 14(9):e0221038. PubMed ID: 31550246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis in people newly diagnosed with HIV at a large HIV care and treatment center in Northwest Cameroon: Burden, comparative screening and diagnostic yields, and patient outcomes.
    Mbu ET; Sauter F; Zoufaly A; Bronsvoort BMC; Morgan KL; Noeske J; Abena JF; Sander MS
    PLoS One; 2018; 13(6):e0199634. PubMed ID: 29944701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial.
    Agizew T; Chihota V; Nyirenda S; Tedla Z; Auld AF; Mathebula U; Mathoma A; Boyd R; Date A; Pals SL; Lekone P; Finlay A
    BMC Infect Dis; 2019 Dec; 19(1):1058. PubMed ID: 31842773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Bandim TBscore--reliability, further development, and evaluation of potential uses.
    Rudolf F
    Glob Health Action; 2014; 7():24303. PubMed ID: 24857613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/μl in 2 low-resource settings: A prospective observational study.
    Huerga H; Mathabire Rucker SC; Cossa L; Bastard M; Amoros I; Manhiça I; Mbendera K; Telnov A; Szumilin E; Sanchez-Padilla E; Molfino L
    PLoS Med; 2019 Apr; 16(4):e1002792. PubMed ID: 31039161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of Clinical Screening Algorithms for Tuberculosis Intensified Case Finding among People Living with HIV in Western Kenya.
    Modi S; Cavanaugh JS; Shiraishi RW; Alexander HL; McCarthy KD; Burmen B; Muttai H; Heilig CM; Nakashima AK; Cain KP
    PLoS One; 2016; 11(12):e0167685. PubMed ID: 27936146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical scoring system to prioritise investigation for tuberculosis among adults attending HIV clinics in South Africa.
    Hanifa Y; Fielding KL; Chihota VN; Adonis L; Charalambous S; Foster N; Karstaedt A; McCarthy K; Nicol MP; Ndlovu NT; Sinanovic E; Sahid F; Stevens W; Vassall A; Churchyard GJ; Grant AD
    PLoS One; 2017; 12(8):e0181519. PubMed ID: 28771504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in Namibia.
    Mavenyengwa RT; Shaduka E; Maposa I
    Infect Dis Poverty; 2017 Jan; 6(1):13. PubMed ID: 28086955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of HIV-1, HIV-2, and HIV-1+2 dual infection on the outcome of tuberculosis.
    Wejse C; Patsche CB; Kühle A; Bamba FJ; Mendes MS; Lemvik G; Gomes VF; Rudolf F
    Int J Infect Dis; 2015 Mar; 32():128-34. PubMed ID: 25499041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of tuberculosis treatment in HIV-positive adults diagnosed through active versus passive case-finding.
    Balcha TT; Skogmar S; Sturegård E; Björkman P; Winqvist N
    Glob Health Action; 2015; 8():27048. PubMed ID: 25819037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda.
    Nakiyingi L; Ssengooba W; Nakanjako D; Armstrong D; Holshouser M; Kirenga BJ; Shah M; Mayanja-Kizza H; Joloba ML; Ellner JJ; Dorman SE; Manabe YC
    BMC Infect Dis; 2015 Feb; 15():62. PubMed ID: 25888317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Test and Treat TB: a pilot trial of GeneXpert MTB/RIF screening on a mobile HIV testing unit in South Africa.
    Bassett IV; Forman LS; Govere S; Thulare H; Frank SC; Mhlongo B; Losina E
    BMC Infect Dis; 2019 Feb; 19(1):110. PubMed ID: 30717693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xpert MTB/RIF diagnosis of childhood tuberculosis from sputum and stool samples in a high TB-HIV-prevalent setting.
    Orikiriza P; Nansumba M; Nyehangane D; Bastard M; Mugisha IT; Nansera D; Mwanga-Amumpaire J; Boum Y; Kumbakumba E; Bonnet M
    Eur J Clin Microbiol Infect Dis; 2018 Aug; 37(8):1465-1473. PubMed ID: 29740714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational study.
    Thit SS; Aung NM; Htet ZW; Boyd MA; Saw HA; Anstey NM; Kyi TT; Cooper DA; Kyi MM; Hanson J
    BMC Med; 2017 Aug; 15(1):145. PubMed ID: 28774293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.